CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. Average Selling Price
3.6. Market Share Analysis
3.7. Brand Share Analysis
3.8. Trade Data Analysis
3.9. Product Consumption
3.10. Value Chain Analysis
3.11. Regulatory Guidelines
3.12. Key Regulation Analysis
3.13. Reimbursement Scenario
3.14. Patent Landscape
CHAPTER 4: GLUCURONOLACTONE MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Powder
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Liquid
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Tablet/Capsule
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: GLUCURONOLACTONE MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Preservatives
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Antioxidants
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Processing Aids and Additives
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Energy Supplements
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: GLUCURONOLACTONE MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Food and Beverages
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Pharmaceuticals
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
CHAPTER 7: GLUCURONOLACTONE MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Type
7.2.3. Market size and forecast, by Application
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Type
7.2.5.1.2. Market size and forecast, by Application
7.2.5.1.3. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Type
7.2.5.2.2. Market size and forecast, by Application
7.2.5.2.3. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Type
7.2.5.3.2. Market size and forecast, by Application
7.2.5.3.3. Market size and forecast, by End User
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Type
7.3.3. Market size and forecast, by Application
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Type
7.3.5.1.2. Market size and forecast, by Application
7.3.5.1.3. Market size and forecast, by End User
7.3.5.2. UK
7.3.5.2.1. Market size and forecast, by Type
7.3.5.2.2. Market size and forecast, by Application
7.3.5.2.3. Market size and forecast, by End User
7.3.5.3. France
7.3.5.3.1. Market size and forecast, by Type
7.3.5.3.2. Market size and forecast, by Application
7.3.5.3.3. Market size and forecast, by End User
7.3.5.4. Spain
7.3.5.4.1. Market size and forecast, by Type
7.3.5.4.2. Market size and forecast, by Application
7.3.5.4.3. Market size and forecast, by End User
7.3.5.5. Italy
7.3.5.5.1. Market size and forecast, by Type
7.3.5.5.2. Market size and forecast, by Application
7.3.5.5.3. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Type
7.3.5.6.2. Market size and forecast, by Application
7.3.5.6.3. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Type
7.4.3. Market size and forecast, by Application
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. China
7.4.5.1.1. Market size and forecast, by Type
7.4.5.1.2. Market size and forecast, by Application
7.4.5.1.3. Market size and forecast, by End User
7.4.5.2. Japan
7.4.5.2.1. Market size and forecast, by Type
7.4.5.2.2. Market size and forecast, by Application
7.4.5.2.3. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Type
7.4.5.3.2. Market size and forecast, by Application
7.4.5.3.3. Market size and forecast, by End User
7.4.5.4. South Korea
7.4.5.4.1. Market size and forecast, by Type
7.4.5.4.2. Market size and forecast, by Application
7.4.5.4.3. Market size and forecast, by End User
7.4.5.5. Australia
7.4.5.5.1. Market size and forecast, by Type
7.4.5.5.2. Market size and forecast, by Application
7.4.5.5.3. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Type
7.4.5.6.2. Market size and forecast, by Application
7.4.5.6.3. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Type
7.5.3. Market size and forecast, by Application
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Type
7.5.5.1.2. Market size and forecast, by Application
7.5.5.1.3. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by Type
7.5.5.2.2. Market size and forecast, by Application
7.5.5.2.3. Market size and forecast, by End User
7.5.5.3. United Arab Emirates
7.5.5.3.1. Market size and forecast, by Type
7.5.5.3.2. Market size and forecast, by Application
7.5.5.3.3. Market size and forecast, by End User
7.5.5.4. South Africa
7.5.5.4.1. Market size and forecast, by Type
7.5.5.4.2. Market size and forecast, by Application
7.5.5.4.3. Market size and forecast, by End User
7.5.5.5. Rest of LAMEA
7.5.5.5.1. Market size and forecast, by Type
7.5.5.5.2. Market size and forecast, by Application
7.5.5.5.3. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Jungbunzlauer
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.2. Shandong Xinhong Pharmaceutical Co., Ltd.
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.3. Shandong Fuyuan Bio-Tech CO.LTD.
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.4. Merck Millipore Corporation
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.5. Shaoxing Marina Biotechnology Co.Ltd.
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.6. Shandong Baisheng Biotechnology Co., Ltd.
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.7. Roquette Freres
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.8. Functional Food chem International Corporation
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.9. Hubei Yitai Pharmaceutical Co.Ltd.
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.10. Anhui Fubore Pharmaceutical & Chemical Co.Ltd.
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
TABLE 01. GLOBAL GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 02. GLUCURONOLACTONE MARKET FOR POWDER, BY REGION, 2022-2032 ($THOUSAND)
TABLE 03. GLUCURONOLACTONE MARKET FOR LIQUID, BY REGION, 2022-2032 ($THOUSAND)
TABLE 04. GLUCURONOLACTONE MARKET FOR TABLET/CAPSULE, BY REGION, 2022-2032 ($THOUSAND)
TABLE 05. GLOBAL GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 06. GLUCURONOLACTONE MARKET FOR PRESERVATIVES, BY REGION, 2022-2032 ($THOUSAND)
TABLE 07. GLUCURONOLACTONE MARKET FOR ANTIOXIDANTS, BY REGION, 2022-2032 ($THOUSAND)
TABLE 08. GLUCURONOLACTONE MARKET FOR PROCESSING AIDS AND ADDITIVES, BY REGION, 2022-2032 ($THOUSAND)
TABLE 09. GLUCURONOLACTONE MARKET FOR ENERGY SUPPLEMENTS, BY REGION, 2022-2032 ($THOUSAND)
TABLE 10. GLOBAL GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 11. GLUCURONOLACTONE MARKET FOR FOOD AND BEVERAGES, BY REGION, 2022-2032 ($THOUSAND)
TABLE 12. GLUCURONOLACTONE MARKET FOR PHARMACEUTICALS, BY REGION, 2022-2032 ($THOUSAND)
TABLE 13. GLUCURONOLACTONE MARKET, BY REGION, 2022-2032 ($THOUSAND)
TABLE 14. NORTH AMERICA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 15. NORTH AMERICA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 16. NORTH AMERICA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 17. NORTH AMERICA GLUCURONOLACTONE MARKET, BY COUNTRY, 2022-2032 ($THOUSAND)
TABLE 18. U.S. GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 19. U.S. GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 20. U.S. GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 21. CANADA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 22. CANADA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 23. CANADA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 24. MEXICO GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 25. MEXICO GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 26. MEXICO GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 27. EUROPE GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 28. EUROPE GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 29. EUROPE GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 30. EUROPE GLUCURONOLACTONE MARKET, BY COUNTRY, 2022-2032 ($THOUSAND)
TABLE 31. GERMANY GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 32. GERMANY GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 33. GERMANY GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 34. UK GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 35. UK GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 36. UK GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 37. FRANCE GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 38. FRANCE GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 39. FRANCE GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 40. SPAIN GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 41. SPAIN GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 42. SPAIN GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 43. ITALY GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 44. ITALY GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 45. ITALY GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 46. REST OF EUROPE GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 47. REST OF EUROPE GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 48. REST OF EUROPE GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 49. ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 50. ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 51. ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 52. ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY COUNTRY, 2022-2032 ($THOUSAND)
TABLE 53. CHINA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 54. CHINA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 55. CHINA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 56. JAPAN GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 57. JAPAN GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 58. JAPAN GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 59. INDIA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 60. INDIA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 61. INDIA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 62. SOUTH KOREA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 63. SOUTH KOREA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 64. SOUTH KOREA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 65. AUSTRALIA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 66. AUSTRALIA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 67. AUSTRALIA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 68. REST OF ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 69. REST OF ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 70. REST OF ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 71. LAMEA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 72. LAMEA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 73. LAMEA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 74. LAMEA GLUCURONOLACTONE MARKET, BY COUNTRY, 2022-2032 ($THOUSAND)
TABLE 75. BRAZIL GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 76. BRAZIL GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 77. BRAZIL GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 78. SAUDI ARABIA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 79. SAUDI ARABIA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 80. SAUDI ARABIA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 81. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 82. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 83. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 84. SOUTH AFRICA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 85. SOUTH AFRICA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 86. SOUTH AFRICA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 87. REST OF LAMEA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 88. REST OF LAMEA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 89. REST OF LAMEA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 90. JUNGBUNZLAUER: KEY EXECUTIVES
TABLE 91. JUNGBUNZLAUER: COMPANY SNAPSHOT
TABLE 92. SHANDONG XINHONG PHARMACEUTICAL CO., LTD.: KEY EXECUTIVES
TABLE 93. SHANDONG XINHONG PHARMACEUTICAL CO., LTD.: COMPANY SNAPSHOT
TABLE 94. SHANDONG FUYUAN BIO-TECH CO.LTD.: KEY EXECUTIVES
TABLE 95. SHANDONG FUYUAN BIO-TECH CO.LTD.: COMPANY SNAPSHOT
TABLE 96. MERCK MILLIPORE CORPORATION: KEY EXECUTIVES
TABLE 97. MERCK MILLIPORE CORPORATION: COMPANY SNAPSHOT
TABLE 98. SHAOXING MARINA BIOTECHNOLOGY CO.LTD.: KEY EXECUTIVES
TABLE 99. SHAOXING MARINA BIOTECHNOLOGY CO.LTD.: COMPANY SNAPSHOT
TABLE 100. SHANDONG BAISHENG BIOTECHNOLOGY CO., LTD.: KEY EXECUTIVES
TABLE 101. SHANDONG BAISHENG BIOTECHNOLOGY CO., LTD.: COMPANY SNAPSHOT
TABLE 102. ROQUETTE FRERES: KEY EXECUTIVES
TABLE 103. ROQUETTE FRERES: COMPANY SNAPSHOT
TABLE 104. FUNCTIONAL FOOD CHEM INTERNATIONAL CORPORATION: KEY EXECUTIVES
TABLE 105. FUNCTIONAL FOOD CHEM INTERNATIONAL CORPORATION: COMPANY SNAPSHOT
TABLE 106. HUBEI YITAI PHARMACEUTICAL CO.LTD.: KEY EXECUTIVES
TABLE 107. HUBEI YITAI PHARMACEUTICAL CO.LTD.: COMPANY SNAPSHOT
TABLE 108. ANHUI FUBORE PHARMACEUTICAL & CHEMICAL CO.LTD.: KEY EXECUTIVES
TABLE 109. ANHUI FUBORE PHARMACEUTICAL & CHEMICAL CO.LTD.: COMPANY SNAPSHOT
